Controlled release of drug model from N-(2-hydroxypropyl)-methacrylamide copolymers.
D000178:Acrylamides / Q000008:administration & dosage* / Q000276:immunology; D000814:Aniline Compounds / Q000008:administration & dosage; D000818:Animals; D001673:Biodegradation, Environmental; D002403:Cathepsins / Q000378:metabolism; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D005688:Galactosamine / Q000378:metabolism; D006868:Hydrolysis; D007700:Kinetics; D008247:Lysosomes / Q000378:metabolism; D008657:Metabolic Clearance Rate; D051379:Mice; D014677:Pharmaceutical Vehicles; D010873:Pinocytosis; D011955:Receptors, Drug
D000178:Acrylamides; D000814:Aniline Compounds; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D014677:Pharmaceutical Vehicles; D011955:Receptors, Drug; C008625:nitroaniline; D005688:Galactosamine; D002403:Cathepsins; C032976:N-(2-hydroxypropyl)methacrylamide